QC Healthcare launched My Adult Doctor nationwide on September 2, 2026, a virtual healthcare platform now available across all 50 states, Puerto Rico, and Guam. The expansion brings 24/7 urgent care, primary care, behavioral health, and chronic disease management to adults through a single digital front door, addressing persistent gaps in access for rural and underserved communities.
The platform builds on the company's existing My Pediatric Doctor service and arrives alongside a strategic collaboration with Massive Bio, an AI-driven oncology data company. That partnership aims to surface clinical trial opportunities for cancer patients who might otherwise never learn about them. QC Healthcare also announced plans for future platforms including My Oncology Doctor and My VA Doctor.
"Our healthcare system has tremendous opportunity to improve how patients access care, how physicians engage with patients, and how technology can support better health outcomes," said Eric Doherty, Chief Executive Officer of QC Healthcare. "QC Healthcare was built around a simple vision: every patient should have access to trusted healthcare whenever and wherever they need it."
What the platform includes
My Adult Doctor offers virtual urgent care for respiratory illnesses, infections, allergies, skin conditions, and minor injuries. The primary care track covers preventive visits, annual wellness evaluations, medication management, and care coordination. Behavioral health services span mental health evaluations, therapy, psychiatry access, and medication management when clinically appropriate.
The platform also enters the metabolic health space with medically supervised wellness programs. Where clinically appropriate and legally permitted, physicians can guide patients using GLP-1 medications and peptide-based therapies. Doherty framed this as one piece of a larger puzzle: "Technology and medications are only one component. The future of healthcare requires combining clinical expertise, patient education, lifestyle support, monitoring, and long-term engagement."
AI integration and clinical research access
QC Healthcare's technology roadmap includes AI-enabled patient engagement tools, intelligent healthcare navigation, automated scheduling, clinical documentation support, and predictive analytics. The company described a physician-led model where technology supports clinical judgment rather than replacing it. For healthcare professionals tracking how AI for Healthcare is being deployed in direct-to-patient settings, the platform offers a real-world example of operational integration across scheduling, documentation, and population health analytics.
The Massive Bio collaboration targets a specific friction point in oncology: community oncologists rarely have the bandwidth to screen every patient against thousands of open trials. "So many patients are treated in community settings where oncologists simply don't have the bandwidth to screen every case against thousands of open trials," said Arturo Loaiza-Bonilla, Co-Founder and Chief Medical AI Officer of Massive Bio. "This collaboration helps close that gap by surfacing relevant trial options for patients earlier in their care."
Selin Kurnaz, Co-Founder and CEO of Massive Bio, added: "Every patient deserves to know what options are available to them, and clinical trials are too often the option they never hear about. By working with QC Healthcare, we can reach patients through a platform they already trust."
Population health and underserved communities
QC Healthcare identified physician shortages, rural healthcare limitations, transportation barriers, and long wait times as core problems its virtual model can address. Future population health initiatives may include collaborations focused on rural access, Native American and tribal healthcare communities, employer health programs, and chronic disease prevention. The company is exploring partnerships with organizations such as the NIH, CDC, and American Cancer Society, though no formal agreements with those entities were announced.
The company's long-term vision connects patients, physicians, health systems, employers, diagnostic organizations, and research partners within a single ecosystem. The stated goal is to improve care coordination, clinical research participation, and health outcomes through tighter integration between traditional care delivery and digital infrastructure. Tools involving Generative AI and LLM capabilities are part of that roadmap, particularly for patient navigation, clinical documentation, and predictive analytics that could flag at-risk populations earlier.
Why this matters for healthcare professionals
For clinicians and health system leaders, My Adult Doctor represents a scaling test of the virtual-first primary care model. The platform's combination of urgent care, longitudinal primary care, behavioral health, and metabolic medicine under one roof mirrors the integrated care models many health systems are trying to build internally. Its explicit focus on clinical trial enrollment through the Massive Bio partnership also signals a push to make research participation a standard part of community-based care rather than an afterthought reserved for academic medical centers. Whether the platform can build lasting patient-provider relationships in a purely virtual setting remains an open question, but the infrastructure is now live at national scale.
Your membership also unlocks:
